Number of the records: 1  

Platinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells

  1. 1.
    SYSNO ASEP0041277
    Document TypeA - Abstract
    R&D Document TypeThe record was not marked in the RIV
    R&D Document TypeNení vybrán druh dokumentu
    TitlePlatinum(IV) complex with adamantylamine overcomes intrinsic resistance to cisplatin in ovarian cancer cells
    TitleČtyřmocný platinový adamantylaminový derivát překonává vnitřní rezistenci k cisplatině v nádorových buňkách ovaria
    Author(s) Horváth, Viktor (BFU-R)
    Blanářová, Olga (BFU-R)
    Šindlerová, Lenka (BFU-R) RID, ORCID
    Souček, Karel (BFU-R) RID, ORCID
    Hofmanová, Jiřina (BFU-R) RID, ORCID
    Sova, Petr (CZ)
    Kroutil, Aleš (CZ)
    Fedoročko, P. (SK)
    Kozubík, Alois (BFU-R) RID, ORCID
    Source TitleAbstracts. - Bratislava : Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, 2006 / Boháčová V. ; Breier A. ; Zbyňovská D. ; Zliechovec J. - ISBN 80-969532-6-5
    s. 296-296
    Number of pages1 s.
    ActionBiochemický zjazd /20./
    Event date12.09.2006-16.09.2006
    VEvent locationPiešťany
    CountrySK - Slovakia
    Event typeEUR
    Languageeng - English
    CountrySK - Slovakia
    Keywordsovarian cancer ; cisplatin ; resistance
    Subject RIVBO - Biophysics
    R&D Projects1QS500040507 GA AV ČR - Academy of Sciences of the Czech Republic (AV ČR)
    PZ-Z2/29 GA MPO - Ministry of Industry and Trade (MPO)
    CEZAV0Z50040507 - BFU-R (2005-2011)
    AnnotationWe described the ability of Pt(IV) complex LA-12 to inhibit proliferation, induce apoptosis and cause cell cycle arrest in the cancer cell line SK-OV-3.
    WorkplaceInstitute of Biophysics
    ContactJana Poláková, polakova@ibp.cz, Tel.: 541 517 244
    Year of Publishing2007
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.